Role of VEGF in organogenesis

Organogenesis

Volumn 4, Issue 4, 2008, Pages 247-256

  Haigh, Jody J ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Angiogenesis; Cardiovascular; Conditional mutagenesis; Cre loxP system; Mouse; Organogenesis; VEGF; VEGF receptors

Indexed keywords

NEUROPILIN 1; NEUROPILIN 2; OXYGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 120; VASCULOTROPIN 121; VASCULOTROPIN 164; VASCULOTROPIN 165; VASCULOTROPIN 188; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL; BONE DEVELOPMENT; CARDIOVASCULAR SYSTEM; CELL MATURATION; ECTODERM; ENDODERM; HEART DEVELOPMENT; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IN VIVO STUDY; LIVER DEVELOPMENT; LUNG DEVELOPMENT; MESODERM; MUSCULOSKELETAL DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUTRIENT UPTAKE; ORGANOGENESIS; OXYGEN CONSUMPTION; PANCREAS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

DANIO RERIO; VERTEBRATA;

EID: 57349153962     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.4.4.7415     Document Type: Review

References (105)

1. Miquerol L, Gertsenstein M, Harpal K et al. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev Biol 1999; 212:307-22.
2. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. Exs 2005; 209-31.
3. Ema M, Taya S, Yokotani N et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997; 94:4273-8.
4. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604-13.
5. Pages G, Pouyssegur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene - a concert of activating factors. Cardiovasc Res 2005; 65:564-73.
6. Fujita M, Mason RJ, Cool C et al. Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol 2002; 93:2162-70.
7. Harada S, Nagy JA, Sullivan KA et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93:2490-6.
8. Ruhrberg C. Growing and shaping the vascular tree: Multiple roles for VEGF. Bioessays 2003; 25:1052-60.
9. Ng YS, Rohan R, Sunday ME et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001; 220:112-21.
10. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-9.
11. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42.
12. Gerber HP, Hillan KJ, Ryan AM et al. VEGF is required for growth and survival in neonatal mice. Development 1999; 126:1149-59.
13. Carmeliet P, Ng YS, Nuyens D et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999; 5:495-502.
14. Stalmans I, Ng YS, Rohan R et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327-36.
15. Stalmans I, Lambrechts D, De Smet F et al. VEGF: A modifier of the del22q11 (DiGeorge) syndrome? Nat Med 2003; 9:173-82.
16. Ruhrberg C, Gerhardt H, Golding M et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002; 16:2684-98.
17. Gerhardt H, Golding M, Fruttiger M et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77.
18. Maes C, Carmeliet P, Moermans K et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002; 111:61-73.
19. Zelzer E, McLean W, Ng YS et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129:1893-904.
20. Mattot V, Moons L, Lupu F et al. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 2002; 13:1548-60.
21. Maes C, Stockmans I, Moermans K et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 2004; 113:188-99.
22. Gustafsson T, Ameln H, Fischer H et al. VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J Appl Physiol 2005; 98:2137-46.
23. Bates DO, Cui TG, Doughty JM et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62:4123-31.
24. Yang SP, Kwon BO, Gho YS et al. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity. J Neurochem 2005; 93:118-27.
25. Risau W. Embryonic angiogenesis factors. Pharmacol Ther 1991; 51:371-6.
26. Sato TN, Lougna S. Vasculogenesis and Angiogenesis. In: Tam JRaPPL, ed. Mouse Development: Patterning, Morphogenesis, and Organogenesis. Academic Press, 2002:211-28.
27. Speck N, Peeters M, Dzierzak E. Development of the vertebrate hematopoietic system. In: Tam JRaPPL, ed. Mouse Development: Patterning, Morphogenesis, and Organogenesis. Academic Press, 2002:191-206.
28. Harvey RP. Molecular determinants of cardiac development and congenital disease. In: Tam JRaPPL, ed. Mouse Development: Patterning, Morphogenesis, and Organogenesis. Academic Press, 2002:332-58.
29. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376:62-6.
30. Shalaby F, Ho J, Stanford WL et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997; 89:981-90.
31. Schuh AC, Faloon P, Hu QL et al. In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc Natl Acad Sci USA 1999; 96:2159-64.
32. Fong GH, Rossant J, Gertsenstein M et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70.
33. Fong GH, Zhang L, Bryce DM et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 1999; 126:3015-25.
34. Hiratsuka S, Minowa O, Kuno J et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998; 95:9349-54.
35. Hiratsuka S, Nakao K, Nakamura K et al. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol 2005; 25:346-54.
36. Hiratsuka S, Kataoka Y, Nakao K et al. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol 2005; 25:355-63.
37. Kearney JB, Kappas NC, Ellerstrom C et al. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 2004; 103:4527-35.
38. Autiero M, Waltenberger J, Communi D et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9:936943.
39. Fujisawa H. From the discovery of neuropilin to the determination of its adhesion sites. Adv Exp Med Biol 2002; 515:1-12.
40. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735-45.
41. Kawasaki T, Kitsukawa T, Bekku Y et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126:4895-902.
42. Takashima S, Kitakaze M, Asakura M et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002; 99:3657-62.
43. Minamisawa S, Gu Y, Ross Jr J et al. A post-transcriptional compensatory pathway in heterozygous ventricular myosin light chain 2-deficient mice results in lack of gene dosage effect during normal cardiac growth or hypertrophy. J Biol Chem 1999; 274:10066-70.
44. Giordano FJ, Gerber HP, Williams SP et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 2001; 98:5780-5.
45. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000; 127:3941-6.
46. Dor Y, Camenisch TD, Itin A et al. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 2001; 128:1531-8.
47. Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell 2004; 7:107-16.
48. Gu C, Rodriguez ER, Reimert DV et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5:45-57.
49. Takahashi N, Seko Y, Noiri E et al. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Circ Res 1999; 84:1194-1202.
50. Motoike T, Markham DW, Rossant J et al. Evidence for novel fate of Flk1+ progenitor: Contribution to muscle lineage. Genesis 2003; 35:153-9.
51. Choi K, Kennedy M, Kazarov A et al. A common precursor for hematopoietic and endothelial cells. Development 1998; 125:725-32.
52. Yamashita J, Itoh H, Hirashima M et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408:92-6.
53. Ema M, Rossant J. Cell fate decisions in early blood vessel formation. Trends Cardiovasc Med 2003; 13:254-9.
54. Ishida A, Murray J, Saito Y et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 2001; 188:359-68.
55. Gerber HP, Malik AK, Solar GP et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002; 417:954-8.
56. Haruta H, Nagata Y, Todokoro K. Role of Flk-1 in mouse hematopoietic stem cells. FEBS Lett 2001; 507:45-8.
57. Hattori K, Dias S, Heissig B et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193:1005-14.
58. Ohm JE, Gabrilovich DI, Sempowski GD et al. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 2003; 101:4878-86.
59. Belteki G, Haigh J, Kabacs N et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cremediated recombination and tetracycline induction. Nucleic Acids Res 2005; 33:e51.
60. Matsumoto K, Yoshitomi H, Rossant J et al. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001; 294:559-63.
61. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001; 294:564-7.
62. Ankoma-Sey V, Matli M, Chang KB et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998; 17:115-21.
63. Wong AK, Alfert M, Castrillon DH et al. Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome. Proc Natl Acad Sci USA 2001; 98:7481-6.
64. LeCouter J, Moritz DR, Li B et al. Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1. Science 2003; 299:890-3.
65. Inoue M, Hager JH, Ferrara N et al. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell 2002; 1:193-202.
66. Lammert E, Gu G, McLaughlin M et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003; 13:1070-4.
67. Compernolle V, Brusselmans K, Acker T et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8:702-10.
68. Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28:131-8.
69. Zeng X, Wert SE, Federici R et al. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 1998; 211:215-27.
70. Le Cras TD, Spitzmiller RE, Albertine KH et al. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 2004; 287:134-42.
71. Lee CG, Link H, Baluk P et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004; 10(10):1095-1103.
72. Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol 2000; 279:F275-82.
73. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111:707-16.
74. Eremina V, Quaggin SE. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004; 13:9-15.
75. Germani A, Di Carlo A, Mangoni A et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003; 163:1417-28.
76. van Weel V, Deckers MM, Grimbergen JM et al. Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. Circ Res 2004; 95:58-66.
77. Gerber HP, Vu TH, Ryan AM et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5:623-8.
78. Haigh JJ, Gerber HP, Ferrara N et al. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 2000; 127:1445-53.
79. Zelzer E, Mamluk R, Ferrara N et al. VEGFA is necessary for chondrocyte survival during bone development. Development 2004; 131:2161-71.
80. Weninger W, Uthman A, Pammer J et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 1996; 75:647-57.
81. Rossiter H, Barresi C, Pammer J et al. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 2004; 64:3508-16.
82. Larcher F, Murillas R, Bolontrade M et al. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 1998; 17:303-11.
83. Xia YP, Li B, Hylton D et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003; 102:161-8.
84. Eichmann A, Makinen T, Alitalo K. Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev 2005; 19:1013-21.
85. Carmeliet P. Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 2003; 4:710-20.
86. Hobson MI, Green CJ, Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 2000; 197:591-605.
87. Jin K, Zhu Y, Sun Y et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99:11946-50.
88. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19:5731-40.
89. Matsuzaki H, Tamatani M, Yamaguchi A et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: Signal transduction cascades. FASEB J 2001; 15:1218-20.
90. Damert A, Miquerol L, Gertsenstein M et al. Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 2002; 129:1881-92.
91. Haigh JJ, Morelli PI, Gerhardt H et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 2003; 262:225-41.
92. Raab S, Beck H, Gaumann A et al. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91:595-605.
93. Schwarz Q, Gu C, Fujisawa H et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev 2004; 18:2822-34.
94. Wada T, Haigh JJ, Ema M et al. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J Neurosci 2006; 26:6803-12.
95. Cao L, Jiao X, Zuzga DS et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004; 36:827-35.
96. Lambrechts D, Storkebaum E, Carmeliet P. VEGF: Necessary to prevent motoneuron degeneration, sufficient to treat ALS- Trends Mol Med 2004; 10:275-82.
97. Carmeliet P, Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: Implications for neurological disorders. Semin Cell Dev Biol 2002; 13:39-53.
98. Azzouz M, Ralph GS, Storkebaum E et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429:413-7.
99. Storkebaum E, Lambrechts D, Dewerchin M et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005; 8:85-92.
100. Fruttiger M. VEGF Gene Regulation. In: Ruhrberg C. VEGF in Development. Austin: Landes Bioscience, 2008:30-9.
101. Ng Y. The Biology of Vascular Endothelial Cell Growth Factor Isoforms. In: Ruhrberg C. VEGF in Development. Austin: Landes Bioscience, 2008:1-13.
102. Goldie L.C., Nix M.K., Hirschi K.K. An embryonic vasculogenesis and hematopoietic specification. Organogenesis 2008; 4:257-63.
103. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008; 4:241-6.
104. Maes C, Carmeliet G. Vascular and Nonvascular Roles of VEGF in Bone Development. In: Ruhrberg C. VEGF in Development. Austin: Landes Bioscience, 2008:79-90.
105. Rosenstein J, Krum J, Ruhrberg C. VEGF in the Nervous System. In: Ruhberg C. VEGF in Development. Austin: Landes Bioscience, 2008;91-104.